← Back
Data updated: Mar 10, 2026
WOODWARD
Infectious Disease
WOODWARD is a specialty pharmaceutical company focused on Infectious Disease.
1999
Since
6
Drugs
-
Trials
17
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER 2026-01-14
Labeling
MILRINONE LACTATE IN DEXTROSE 5% 2025-09-02
FLUCONAZOLE IN DEXTROSE 5% IN PLASTIC CONTAINER 2025-04-25
Labeling
FLUCONAZOLE IN DEXTROSE 5% IN PLASTIC CONTAINER 2025-04-25
Labeling
FLUCONAZOLE IN DEXTROSE 5% IN PLASTIC CONTAINER 2025-04-25
Labeling
FLUCONAZOLE IN DEXTROSE 5% IN PLASTIC CONTAINER 2025-04-25
Labeling
FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER 2025-04-25
Labeling
FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER 2025-04-25
Labeling
FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER 2025-04-25
Labeling
FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER 2025-04-25
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Infectious Disease 100%
1 drugs
Pipeline Strength Pro
Loading...
Discontinued (5)
Company Info
- First Approval
- 1999-05-25
- Latest
- 2021-10-12
- Applications
- 5